Rhinovirus Clinical Trial
— IPCoVRS-2Official title:
Impact of the Covid-19 Pandemic on the Epidemiology of Respiratory Syncytial Virus in the Metropolis of Lyon
NCT number | NCT05348655 |
Other study ID # | 502_3 |
Secondary ID | |
Status | Not yet recruiting |
Phase | |
First received | |
Last updated | |
Start date | June 2022 |
Est. completion date | July 2025 |
The magnitude of seasonal RSV epidemics brings each year new logistical challenges for the hospitalization of young infants with bronchiolitis that overwhelm hospital capacities and lead to specific winter plans with deprogramming and mobilization of human and logistical resources. The Covid-19 pandemic has changed the way winter epidemics are presented. For example, the seasonal RSV epidemic was shifted by several months in Lyon, with an impression of a lower incidence of hospitalized cases, with a population of older children and with fewer signs of clinical severity. This is largely attributable to the widespread use of barrier gestures and social distancing measures, known as "non-pharmacological interventions" or NPI. Given the magnitude of the reduction of the RSV epidemic, it is legitimate to analyze the benefits of NPIs to draw lessons for maintaining preventive measures around RSV-vulnerable populations; moreover, new preventive pharmacological interventions are soon to be marketed, whether they are particularly refined and long half-life anti-RSV monoclonal antibodies, RSV vaccines for mothers or for newborns and infants. In this perspective, it is crucial to properly define the populations at risk of severe disease to establish a legitimate hierarchy in the implementation of different preventive strategies. The study of the RSV epidemic is a high potential model because of the convergence of epidemiological, virological, and pharmacological knowledge. However, the study of the impact of the pandemic on the epidemiology of rhinovirus also seems promising because, for reasons unknown to date, it seems that the pandemic did not have the same reducing impact on the rhinovirus epidemic; in the latter case, the interest is to confirm the resistance of this virus and to look for more fundamental explanations, for example, on viral interactions. On a previous study (see NTC 04944160), 519 infants were recruited in the Pre-Covid-19 season population, and 277 infants were recruited in the first Per-Covid-19 season population.
Status | Not yet recruiting |
Enrollment | 600 |
Est. completion date | July 2025 |
Est. primary completion date | July 2025 |
Accepts healthy volunteers | No |
Gender | All |
Age group | N/A to 5 Years |
Eligibility | Inclusion Criteria: - Child hospitalized at " Hôpital Femme Mère Enfant ", Lyon, France - Positive RSV-PCR Exclusion Criteria: - Parent's refusal to participate |
Country | Name | City | State |
---|---|---|---|
France | Pediatric Departement | Lyon | |
France | Virology Lab | Lyon |
Lead Sponsor | Collaborator |
---|---|
Hospices Civils de Lyon |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Annual evolution of the number and severity of RSV-infection in hospitalized children during per-Covid-19 epidemic compared to pre-Covid-19 pandemic. | Description of number of cases for each clinical picture according to pre-SARS-CoV-2 pandemic and per-SARS-CoV-2 pandemic year. | Day 0 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02984280 -
Specific Respiratory Infections as Triggers of Acute Medical Events
|
N/A | |
Completed |
NCT01158560 -
A Trial of Vitamin D and Health Advice for the Prevention of Upper Respiratory Tract Infections
|
Phase 3 | |
Completed |
NCT03605862 -
Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection
|
Phase 3 | |
Recruiting |
NCT06149494 -
RCT of Vapendavir in Patients With COPD and Human Rhinovirus/Enterovirus Upper Respiratory Infection
|
Phase 2 | |
Not yet recruiting |
NCT05348616 -
Impact of the Covid-19 on RSV
|
||
Not yet recruiting |
NCT05348707 -
Impact of Covid-19 on Rhinovirus Epidemic
|
||
Recruiting |
NCT04489381 -
Trial to Evaluate Efficacy and Safety of Nitazoxanide in the Treatment of Colds Due to Enterovirus/Rhinovirus Infection
|
Phase 3 | |
Completed |
NCT04670627 -
Biomarkers in Nasal Samples of Seasonal Allergic Rhinitics
|
||
Suspended |
NCT03508479 -
Study of Airway Inflammatory Responses to Experimental Rhinovirus Infection
|
Phase 1 | |
Completed |
NCT02438293 -
'The Impact of Rhinovirus Infections in Paediatric Cardiac Surgery'
|
||
Completed |
NCT05016687 -
First-in-human Clinical Trial Evaluating CUR-N399 in Healthy Volunteers.
|
Phase 1 | |
Completed |
NCT02660489 -
Effect of OC459 on the Response to Rhinovirus Challenge in Asthma
|
Phase 2 | |
Completed |
NCT02522832 -
Discovering New Treatments for Asthma and COPD. A New Human Rhinvovirus for Human Challenge
|
N/A | |
Completed |
NCT01302418 -
Collection and Testing of Respiratory Samples
|
N/A | |
Completed |
NCT01249625 -
The Respiratory Protection Effectiveness Clinical Trial
|
N/A | |
Completed |
NCT01175226 -
A Phase 2 Study of BTA798 in Asthmatic Adults With Symptomatic Human Rhinovirus Infection
|
Phase 2 | |
Completed |
NCT00394914 -
Effects of Pleconaril Nasal Spray on Common Cold Symptoms and Asthma Exacerbations Following Rhinovirus Exposure (Study P04295)
|
Phase 2 | |
Withdrawn |
NCT03024177 -
A Study of Vapendavir Treatment of Hematopoietic Stem Cell Transplant Subjects With Symptomatic Rhinovirus Infection
|
Phase 2 |